Royal Bank of Canadahttps://www.rbcroyalbank.com/personal.htmlhttps://www.rbcroyalbank.com/personal.htmlInsights1200630enCA
Datum[@Name='Source DCR']
2020-05-26New business models emergeWill genetics usher in a new era of healthcare? Is the entire health ecosystem ready for reinvention? Can digital healthcare in life sciences exceed patient expectations?Expanding Ecosystems3/assets/rbccm/images/gib/healthcare/article_3_thumbnail_sm.jpg/assets/rbccm/images/gib/healthcare/article_3_thumbnail.jpg<h3>Shifting Paradigms</h3>
<p>As the convergence of healthcare and technology has accelerated, new business models are rapidly emerging. </p>
<p>In the traditional biopharma model, the customer would be a physician, R&D tools would be chemical or biological, the end product a pill or vial, and the competitors pharma and biotech players.</p>
<p>The digital revolution in healthcare is shifting this long-established paradigm. Today, biopharma companies’ customer groups have grown to include patients of all ages, providers and payers—all equipped with smartphones and apps that generate a vast amount of digital information to empower their decision-making. R&D has added genetic information and digital capability to its toolset. The end product has broadened beyond the pill to include health outcomes enabled by digital devices and therapeutics. And the competitive set has seen the addition of technology players, including consumer-focused apps and online services, as well as digital health and digital therapeutics firms.</p>
<p class="photo-frame text-center"><img style="width: 100%;" src="/assets/rbccm/images/gib/healthcare/Healthcare-Article-3-Graph-1.png" alt="" /></p>
<h3>A Changing Ecosystem</h3>
<p>Indeed, digital and AI applications are radically changing key areas of the biopharma ecosystem and how patients manage their healthcare.</p>
<p>In pre-clinical research, technology is enabling everything from a deeper mining of literature, to predictive modeling and gene-function annotation. Digital apps are simulating molecular dynamics and pushing the limits of cellular imaging.</p>
<p>In clinical trials, digital transformation is helping to automate testing procedures, build global patient databases and collect real-world data.</p>
<p>In diagnostics, tech powers digital pathology, home-based body diagnosis, and computational analysis of tissue arrays. Just like your car leaves the factory with hundreds of sensors that can trigger the check engine light, humans will have wearable and/or implantable sensors to alert them when something is not functioning properly. Another burgeoning area is immune cell monitoring and digital analysis through just a finger prick.</p>
<p>At the point of patient care, digital applications are already delivering virtual consultations, remote monitoring, VR-based cognitive therapy and digital Rx. Demand for telehealth services and health-based social platforms is also increasing and especially vital in a world facing new challenges such as the COVID-19 pandemic.</p>
<p><img src="/assets/rbccm/images/gib/healthcare/healthcare-article-3-graph-2.png" alt="AI and Digital applications are changing key areas of the Healthcare Ecosystem" /></p>
<div id="similar-to-this" style="border-top: 2px #E6E6E7 dotted; border-bottom: 2px #E6E6E7 dotted; margin: 35px 0; padding: 25px;">
<h4 style="font-size: 18px; letter-spacing: 0.5px; border-bottom: 3px #FEDF01 solid; padding: 0 0 8px 0; margin-bottom: 15px;">Similar to this</h4>
</div>
<h3>Digital Transformation</h3>
<p>The digital revolution presents both threats and opportunities to incumbent biopharma companies. Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities from treatment to prevention.</p>
<div class="quotebox">
<p>“Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities.”</p>
<p class="attribution" style="color: #0070a3;">– Greg Wiederrecht, Ph.D.</p>
<div class="quote-share">
<p style="display: inline-block;"><span style="margin-right: 15px;">Share </span><a class="blue-circle-outline-sm" href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New%20healthcare%20business%20models%20emerge&source=www.rbccm.com" target="_blank" rel="noopener" aria-label="Connect by LinkedIn"><em class="fa fa-linkedin" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="https://twitter.com/home?status=New%20business%20models%20emerge%20https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge" target="_blank" rel="noopener" aria-label="Connect by X"><em class="fa fa-twitter" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="mailto:?subject=New%20business%20models%20emerge&body=I%20found%20this%20insights%20piece%20from%20RBC%20Capital%20Markets%20informative%20and%20thought%20it%20might%20be%20of%20interest%20to%20you%3A%0D%0Dhttps%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New business models emerge" aria-label="Connect by Email"><em class="fa fa-envelope" style="color: #0051a5; margin-left: 3px;"> </em></a></p>
</div>
</div>
<p> </p>
<p>The increased digitization of human experiences gives access to a wealth of information and knowledge that could help intervene before disease has a chance to strike. A prime example of this is collating data from an Apple Watch to screen for irregular heart rhythms and detect undiagnosed atrial fibrillation. At the other end of the spectrum, digital transformation allows a completely new class of therapies such as digital therapeutics to support specific disorders.</p>
<p>McKinsey and Company’s international survey shows that more than 75% of patients expect to use digital healthcare services in the future.<sup>1</sup> Patients are seeking technology that delivers a level of care they can rely on and trust. Ultimately, the aim of the digital revolution is to develop healthier societies and lower the cost of care.</p>
<p style="word-wrap: break-word;"><sup>1 Source: McKinsey and Company, Healthcare’s Digital Future, July 2014. https://www.mckinsey.com/~/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/Healthcares%20digital%20future/Healthcares%20digital%20future.ashx</sup></p><ul>
<li>Customer groups, R&D and competitors are all rapidly expanding</li>
<li>Tech is reinventing every facet of the biopharma ecosystem</li>
<li>Innovations in patient care is driving adoption of digital services</li>
</ul>text2 min1 minHealthcare Models, Digital Healthcare, Digital Healthcare Apps, Digital Health Diagnostics, Expanding R&D, Healthcare & Tech Convergence, Healthcare Services, Clinical Trials, Remote Patient Monitoring, Digital Therapeutics, Biopharma ecosystem, Cost of CareN/templatedata/rbccm/episode/data/healthcare/amazon_cvs_and_google_healthcare_reimagined/templatedata/rbccm/episode/data/healthcare/big_tech_vs_big_pharma/templatedata/rbccm/episode/data/healthcare/the_healthcare_data_explosionGreg Wiederrecht, Ph.D./assets/rbccm/images/gib/healthcare/greg-wiederrecht.jpgManaging Director, Healthcare Investment Bankinggreg.wiederrecht@rbccm.comhttps://www.linkedin.com/in/gregwiederrecht/Sasson Darwish/assets/rbccm/images/gib/healthcare/sasson-darwish.jpgManaging Director, AI, Analytics and IoT & Israel Country Coverage, Global Technology Investment Bankingsasson.darwish@rbccm.com https://www.linkedin.com/in/sassdarwish/Andrew Callaway/assets/rbccm/images/gib/healthcare/andrew-callaway.jpgManaging Director, Global Head of Healthcare Investment Bankingandrew.callaway@rbccm.comhttps://www.linkedin.com/in/andrew-cal-callaway
DEBUG: DCR
DCR
Royal Bank of Canadahttps://www.rbcroyalbank.com/personal.htmlhttps://www.rbcroyalbank.com/personal.htmlInsights1200630enCA
DCR
2020-05-26New business models emergeWill genetics usher in a new era of healthcare? Is the entire health ecosystem ready for reinvention? Can digital healthcare in life sciences exceed patient expectations?Expanding Ecosystems3/assets/rbccm/images/gib/healthcare/article_3_thumbnail_sm.jpg/assets/rbccm/images/gib/healthcare/article_3_thumbnail.jpg<h3>Shifting Paradigms</h3>
<p>As the convergence of healthcare and technology has accelerated, new business models are rapidly emerging. </p>
<p>In the traditional biopharma model, the customer would be a physician, R&D tools would be chemical or biological, the end product a pill or vial, and the competitors pharma and biotech players.</p>
<p>The digital revolution in healthcare is shifting this long-established paradigm. Today, biopharma companies’ customer groups have grown to include patients of all ages, providers and payers—all equipped with smartphones and apps that generate a vast amount of digital information to empower their decision-making. R&D has added genetic information and digital capability to its toolset. The end product has broadened beyond the pill to include health outcomes enabled by digital devices and therapeutics. And the competitive set has seen the addition of technology players, including consumer-focused apps and online services, as well as digital health and digital therapeutics firms.</p>
<p class="photo-frame text-center"><img style="width: 100%;" src="/assets/rbccm/images/gib/healthcare/Healthcare-Article-3-Graph-1.png" alt="" /></p>
<h3>A Changing Ecosystem</h3>
<p>Indeed, digital and AI applications are radically changing key areas of the biopharma ecosystem and how patients manage their healthcare.</p>
<p>In pre-clinical research, technology is enabling everything from a deeper mining of literature, to predictive modeling and gene-function annotation. Digital apps are simulating molecular dynamics and pushing the limits of cellular imaging.</p>
<p>In clinical trials, digital transformation is helping to automate testing procedures, build global patient databases and collect real-world data.</p>
<p>In diagnostics, tech powers digital pathology, home-based body diagnosis, and computational analysis of tissue arrays. Just like your car leaves the factory with hundreds of sensors that can trigger the check engine light, humans will have wearable and/or implantable sensors to alert them when something is not functioning properly. Another burgeoning area is immune cell monitoring and digital analysis through just a finger prick.</p>
<p>At the point of patient care, digital applications are already delivering virtual consultations, remote monitoring, VR-based cognitive therapy and digital Rx. Demand for telehealth services and health-based social platforms is also increasing and especially vital in a world facing new challenges such as the COVID-19 pandemic.</p>
<p><img src="/assets/rbccm/images/gib/healthcare/healthcare-article-3-graph-2.png" alt="AI and Digital applications are changing key areas of the Healthcare Ecosystem" /></p>
<div id="similar-to-this" style="border-top: 2px #E6E6E7 dotted; border-bottom: 2px #E6E6E7 dotted; margin: 35px 0; padding: 25px;">
<h4 style="font-size: 18px; letter-spacing: 0.5px; border-bottom: 3px #FEDF01 solid; padding: 0 0 8px 0; margin-bottom: 15px;">Similar to this</h4>
</div>
<h3>Digital Transformation</h3>
<p>The digital revolution presents both threats and opportunities to incumbent biopharma companies. Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities from treatment to prevention.</p>
<div class="quotebox">
<p>“Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities.”</p>
<p class="attribution" style="color: #0070a3;">– Greg Wiederrecht, Ph.D.</p>
<div class="quote-share">
<p style="display: inline-block;"><span style="margin-right: 15px;">Share </span><a class="blue-circle-outline-sm" href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New%20healthcare%20business%20models%20emerge&source=www.rbccm.com" target="_blank" rel="noopener" aria-label="Connect by LinkedIn"><em class="fa fa-linkedin" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="https://twitter.com/home?status=New%20business%20models%20emerge%20https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge" target="_blank" rel="noopener" aria-label="Connect by X"><em class="fa fa-twitter" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="mailto:?subject=New%20business%20models%20emerge&body=I%20found%20this%20insights%20piece%20from%20RBC%20Capital%20Markets%20informative%20and%20thought%20it%20might%20be%20of%20interest%20to%20you%3A%0D%0Dhttps%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New business models emerge" aria-label="Connect by Email"><em class="fa fa-envelope" style="color: #0051a5; margin-left: 3px;"> </em></a></p>
</div>
</div>
<p> </p>
<p>The increased digitization of human experiences gives access to a wealth of information and knowledge that could help intervene before disease has a chance to strike. A prime example of this is collating data from an Apple Watch to screen for irregular heart rhythms and detect undiagnosed atrial fibrillation. At the other end of the spectrum, digital transformation allows a completely new class of therapies such as digital therapeutics to support specific disorders.</p>
<p>McKinsey and Company’s international survey shows that more than 75% of patients expect to use digital healthcare services in the future.<sup>1</sup> Patients are seeking technology that delivers a level of care they can rely on and trust. Ultimately, the aim of the digital revolution is to develop healthier societies and lower the cost of care.</p>
<p style="word-wrap: break-word;"><sup>1 Source: McKinsey and Company, Healthcare’s Digital Future, July 2014. https://www.mckinsey.com/~/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/Healthcares%20digital%20future/Healthcares%20digital%20future.ashx</sup></p><ul>
<li>Customer groups, R&D and competitors are all rapidly expanding</li>
<li>Tech is reinventing every facet of the biopharma ecosystem</li>
<li>Innovations in patient care is driving adoption of digital services</li>
</ul>text2 min1 minHealthcare Models, Digital Healthcare, Digital Healthcare Apps, Digital Health Diagnostics, Expanding R&D, Healthcare & Tech Convergence, Healthcare Services, Clinical Trials, Remote Patient Monitoring, Digital Therapeutics, Biopharma ecosystem, Cost of CareN/templatedata/rbccm/episode/data/healthcare/amazon_cvs_and_google_healthcare_reimagined/templatedata/rbccm/episode/data/healthcare/big_tech_vs_big_pharma/templatedata/rbccm/episode/data/healthcare/the_healthcare_data_explosionGreg Wiederrecht, Ph.D./assets/rbccm/images/gib/healthcare/greg-wiederrecht.jpgManaging Director, Healthcare Investment Bankinggreg.wiederrecht@rbccm.comhttps://www.linkedin.com/in/gregwiederrecht/Sasson Darwish/assets/rbccm/images/gib/healthcare/sasson-darwish.jpgManaging Director, AI, Analytics and IoT & Israel Country Coverage, Global Technology Investment Bankingsasson.darwish@rbccm.com https://www.linkedin.com/in/sassdarwish/Andrew Callaway/assets/rbccm/images/gib/healthcare/andrew-callaway.jpgManaging Director, Global Head of Healthcare Investment Bankingandrew.callaway@rbccm.comhttps://www.linkedin.com/in/andrew-cal-callaway
12020-09-14The Emerging Markets Report - September 2020The Emerging Markets Report is a new monthly report where our experts sit down and discuss current trends, investment strategies, and government policies in emerging markets around the world. This month, Adam Cole, RBC’s Chief Currency Strategist, sat down with our three emerging markets strategists, Daniel Rico, Alvin Tan and Dasha Parkhomenko, to discuss quantitative easing in emerging markets.Insights/assets/rbccm/images/insights/2020/20-287A_Emerging-Markets-Report_Banner_1920x475_th.jpg/assets/rbccm/images/insights/2020/20-287A_Emerging-Markets-Report_Banner_1920x475_Final.jpghttps://www.rbccm.com/en/insights/story.page?dcr=templatedata/article/insights/data/2020/09/the_emerging_markets_report<h2>Quantitative Easing (QE) is in the relatively early stages in emerging markets, who is doing QE and how are they doing it in your region?</h2>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question1-LatinAmerica.mp3" type="audio/mpeg" />
Your browser does not support the audio tag.
</audio></p>
<h3>Latin America</h3>
<ul>
<li>In Latin America, several Central Banks have implemented QE type measures in order to provide ample liquidity to stabilize the FX and credit markets.</li>
<li>Colombia and Chile started with modest QE programs, while Brazil changed the legal framework in May to allow for QE.</li>
<li>More recently, the discussion has focus on using Pension Funds resources as direct transfers to spenders while providing explicit government guarantees.</li>
</ul>
<div style="background: #fee100; margin: 25px 0px; height: 4px; clear: both; max-width: 75px;"> </div>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question1-Asia.mp3" /><img src="/assets/rbccm/images/insights/2020/emerging-market-report-1.png" alt="" />
Your browser does not support the audio tag.
</audio></p>
<h3>Asia</h3>
<ul>
<li>In Asia, Indonesia has been on the forefront of unconventional monetary policy, with Bank Indonesia purchasing government debt directly.</li>
<li>The consequence has been a weaker Indonesian rupiah in the third quarter after strong gains in the second quarter.</li>
<li>The Philippines has also been undertaking QE, though primarily through the secondary market. India too has dabbled in unconventional policies, though the RBI has not yet launched a QE program.</li>
</ul>
<div style="background: #fee100; margin: 25px 0px; height: 4px; clear: both; max-width: 75px;"> </div>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question1-Europe-Africa.mp3" />
Your browser does not support the audio tag.
</audio></p>
<h3>Europe and Africa</h3>
<ul>
<li>In EMEA, countries such as Turkey, South Africa, and Poland have introduced QE-type measures.</li>
<li>Poland has had one of the largest bond-buying programs across EM since the COVID-19 crisis started (~4.5% of 2019 GDP since the announcement in March).</li>
<li>In South Africa, the SARB has been strongly against QE to fund the government’s deficit, but if the country does not address its fiscal and growth issues, then questions/market concerns about whether the SARB will be forced to step in with a more aggressive bond-buying program are likely to rise.</li>
</ul>
<div style="background: #fee100; margin: 25px 0px; height: 4px; clear: both; max-width: 75px;"> </div>
<h2>What opportunities do you see for QE in the future? How do you think it will play out for currencies?</h2>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question2-LatinAmerica.mp3" />
Your browser does not support the audio tag.
</audio></p>
<h3>Latin America</h3>
<ul>
<li>This time not only Central Banks had to cut rates and inject liquidity into the markets either by buying Treasury or Corporate bonds or expanding liquidity facilities, but governments had to implement direct cash transfers to their citizens.</li>
<li>This year these stimulus have been funded by increasing international and local debt issuances or multilateral financing</li>
<li>However, the problem is, how sensitive the economic recovery of these countries will be to the necessary fiscal adjustment.</li>
<li>In our view, QE in EM and specially in Latam has opened a Pandora box that similarly to DM will be very hard to close and governments will have no other option except to continue to rely on Central Banks intervention for years to come.</li>
<li>Latin America countries will continue to face pressures on the exchange rate while the Central Banks will be forced to keep expanding the monetary base.</li>
</ul>
<div style="background: #fee100; margin: 25px 0px; height: 4px; clear: both; max-width: 75px;"> </div>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question2-Asia.mp3" />
Your browser does not support the audio tag.
</audio></p>
<h3>Asia</h3>
<ul>
<li>Indonesia's QE experiment has generally been seen as positive, with Indonesian bond yields declining and the rupiah holding onto most of its second quarter gains.</li>
<li>Bank Indonesia has policy credibility among foreign investors, though that reputation could start to wane if BI's "burden-sharing" arrangements were to continue well into next year.</li>
<li>India is likely to be the next Asian central bank to pursue QE. India’s limited fiscal space and elevated inflation have narrowed conventional policy options.</li>
</ul>
<div style="background: #fee100; margin: 25px 0px; height: 4px; clear: both; max-width: 75px;"> </div>
<p><audio controls="controls">
<source src="/assets/rbccm/audio/EmergingMarkets-Question2-Europe-Africa.mp3" />
Your browser does not support the audio tag.
</audio></p>
<h3>Europe and Africa</h3>
<ul>
<li>Despite the large scale of the bond-buying program in Poland, the Polish zloty has been quite resilient.</li>
<li>We think there are three potential factors behind its resiliency – (a) the program has been in coordination with the country’s fiscal response, (b) Poland will benefit from the EU Recovery Fund, and (c) June & July activity data releases have surprised to the upside.</li>
</ul>audio2 minEmerging Markets, Emerging Markets Report, Report, Quantitative Easing, CurrenciesenglobalNinsightsNyesN/templatedata/article/insights/data/2020/08/the_10-minute_take/templatedata/article/insights/data/2020/07/the_10-minute_take/templatedata/article/insights/data/2020/08/how_apple_became_the_most_valuable_public_company_in_the_worldThis month, Adam Cole, RBC’s Chief Currency Strategist, sat down with our three emerging markets strategists, Daniel Rico, Alvin Tan and Dasha Parkhomenko, to discuss quantitative easing in emerging markets.
The Emerging Markets Report is a new monthly report where our experts sit down and discuss current trends, investment strategies, and government policies in emerging markets around the world. This month, Adam Cole, RBC’s Chief Currency Strategist, sat down with our three emerging markets strategists, Daniel Rico, Alvin Tan and Dasha Parkhomenko, to discuss quantitative easing in emerging markets.
Quantitative Easing (QE) is in the relatively early stages in emerging markets, who is doing QE and how are they doing it in your region?
Latin America
In Latin America, several Central Banks have implemented QE type measures in order to provide ample liquidity to stabilize the FX and credit markets.
Colombia and Chile started with modest QE programs, while Brazil changed the legal framework in May to allow for QE.
More recently, the discussion has focus on using Pension Funds resources as direct transfers to spenders while providing explicit government guarantees.
Asia
In Asia, Indonesia has been on the forefront of unconventional monetary policy, with Bank Indonesia purchasing government debt directly.
The consequence has been a weaker Indonesian rupiah in the third quarter after strong gains in the second quarter.
The Philippines has also been undertaking QE, though primarily through the secondary market. India too has dabbled in unconventional policies, though the RBI has not yet launched a QE program.
Europe and Africa
In EMEA, countries such as Turkey, South Africa, and Poland have introduced QE-type measures.
Poland has had one of the largest bond-buying programs across EM since the COVID-19 crisis started (~4.5% of 2019 GDP since the announcement in March).
In South Africa, the SARB has been strongly against QE to fund the government’s deficit, but if the country does not address its fiscal and growth issues, then questions/market concerns about whether the SARB will be forced to step in with a more aggressive bond-buying program are likely to rise.
What opportunities do you see for QE in the future? How do you think it will play out for currencies?
Latin America
This time not only Central Banks had to cut rates and inject liquidity into the markets either by buying Treasury or Corporate bonds or expanding liquidity facilities, but governments had to implement direct cash transfers to their citizens.
This year these stimulus have been funded by increasing international and local debt issuances or multilateral financing
However, the problem is, how sensitive the economic recovery of these countries will be to the necessary fiscal adjustment.
In our view, QE in EM and specially in Latam has opened a Pandora box that similarly to DM will be very hard to close and governments will have no other option except to continue to rely on Central Banks intervention for years to come.
Latin America countries will continue to face pressures on the exchange rate while the Central Banks will be forced to keep expanding the monetary base.
Asia
Indonesia's QE experiment has generally been seen as positive, with Indonesian bond yields declining and the rupiah holding onto most of its second quarter gains.
Bank Indonesia has policy credibility among foreign investors, though that reputation could start to wane if BI's "burden-sharing" arrangements were to continue well into next year.
India is likely to be the next Asian central bank to pursue QE. India’s limited fiscal space and elevated inflation have narrowed conventional policy options.
Europe and Africa
Despite the large scale of the bond-buying program in Poland, the Polish zloty has been quite resilient.
We think there are three potential factors behind its resiliency – (a) the program has been in coordination with the country’s fiscal response, (b) Poland will benefit from the EU Recovery Fund, and (c) June & July activity data releases have surprised to the upside.
This month, Adam Cole, RBC’s Chief Currency Strategist, sat down with our three emerging
markets strategists, Daniel Rico, Alvin Tan and Dasha Parkhomenko, to discuss quantitative
easing in emerging markets.